Emma Asma Cornwall
0
All posts from Emma Asma Cornwall
Emma Asma Cornwall in Gainers & Losers,

BioDelivery Sciences is deeply oversold

The biotech sector is finally starting to recover after a bear market that saw the major biotech indices slump more than 40% from their summer peaks by February.

Of course small cap biotech stocks suffered the most. So may be it's time to look into this segment for really oversold stocks.

BioDelivery Sciences International is a specialty pharmaceutical company based in Raleigh, North Carolina. The company engages in the development and commercialization of pharmaceutical products principally in the areas of pain management and addiction. The company has market capitalization of under $200 million. Not going into detail, analysts are talking about 200-300% upside of this stock. Well at least it's worth some reseach!

From technical point of view, there's a falling wedge on weekly chart, and a bounce looks imminent...